A Study of LY3006072 in Healthy Participants

NCT01640249 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

18

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated due to unacceptable pharmacokinetic (PK) profile.

Conditions

Healthy Volunteers

Interventions

DRUG: Placebo
DRUG: LY3006072

Sponsor

Eli Lilly and Company